Evaluation of ATG5 Gene Expression in Human Induced Pluripotent Stem Cells During Endoderm Induction

AUTHORS

Alice Sabet 1 , 2 , Negar Azarpira ORCID 3 , * , Saeid Ghavami 4 , Leila Kohan 5

1 Department of Genetics, Fars Science and Research Branch, Islamic Azad University, Marvdasht, Iran

2 Department of Genetics, Marvdasht Branch, Islamic Azad University, Marvdasht, Iran

3 Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Department of Human Anatomy and Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada

5 Department of Biology, Arsanjan Branch, Islamic Azad University, Arsanjan, Iran

How to Cite: Sabet A, Azarpira N, Ghavami S, Kohan L. Evaluation of ATG5 Gene Expression in Human Induced Pluripotent Stem Cells During Endoderm Induction, Gene Cell Tissue. Online ahead of Print ; 8(1):e110361. doi: 10.5812/gct.110361.

ARTICLE INFORMATION

Gene, Cell and Tissue: 8 (1); e110361
Published Online: November 24, 2020
Article Type: Research Article
Received: October 19, 2020
Accepted: October 20, 2020
Crossmark
Crossmark
CHECKING
READ FULL TEXT

Abstract

Background: Autophagy is a vital cell survival mechanism that authorizes cells to assort to metabolic stress and is essential for the development and maintenance of cellular and tissue homeostasis, as well as the prevention of human disease. It has also been shown that autophagy plays a significant role in the development and differentiation of stem cells, as well as induced pluripotent stem cells (iPSCs).

Objectives: The present study aimed to examine the mRNA expression of the ATG5 gene, one of the key markers of autophagy in human iPSCs (hiPSCs) during endoderm induction.

Methods: In this study, we cultured the human iPSC line (R1-hiPSC1) on mitomycin-C, inactivated mouse embryonic fibroblasts (MEF) layer, and used hanging drop protocol to generate embryoid body (EB) and expose differentiation. The Real-time PCR method was used to examine the mRNA expression level of ATG5 in hiPSC during endoderm induction.

Results: Our results demonstrated the high mRNA expression of ATG5 in the mesendoderm induction (MEI) stage, which shows the high rate of autophagy in MEI days rather than the other stages of differentiation.

Conclusions: The modification of ATG5 gene expression within hiPSC during endoderm induction shows the importance of autophagy assessments in hiPSC differentiation. Therefore, subsequent studies are needed to clarify the details of autophagy effects on hiPSC differentiation.

1. Background

The characteristics of pluripotency can be achieved by ectopic expression of specific transcription factors in embryonic stem cell (ESC)-like cells can reprogram and generate induced pluripotent stem cells (iPSCs), which has created a new generation of therapy and research (1). The human iPSCs (hiPSC) and human ESCs (hESC) can be self-renewed and differentiated into all human cells when exposed to the proper developmental cues (2). Thus, these differentiated cells can be used as a source in a wide range of experiments to test potential treatments and drugs for diseases. Despite the high qualities of ESCs to differentiate toward different types of cells, the utilization of human ESCs has an ethical concern because they are acquired from the inner cell mass of blastocysts (3).

Unlike hESCs, iPSCs are generated from wholly differentiated adult donor cells. They contribute the same hereditary data with the donor and are detected as own cells by the donor’s immune system, which provides the inspiring ability for therapies with patient-derived iPSCs and does not need to suppress the immune system (4). Stem-cells are a reproducible and almost limitless source of transplantable cells and tissues used in disease therapies. All these ongoing and supreme improvements in the cell transplantation field require methods to generate high-quality cells, techniques to suppress the immune system, or strategies to differentiate stem-cells into favorable functional cells (5).

As the main modulator, autophagy is an extremely-conserved procedure, which helps attain accurate morphology and function of cells via the regulation of protein modification (6). Two processes for ubiquitin-like conjugation are needed to produce the autophagosomes. Autophagy-related gene (ATG) 5 is essential for both of these pathways. Recent reports have shown high rates of autophagy activity during iPSC derivation and maintenance (6). Furthermore, autophagy-related proteins (ATG) can increase autophagy and inhibit endoplasmic reticulum stress (7).

2. Objectives

The current study aimed to examine the mRNA expression of the main autophagy marker gene (ATG5) in different differentiation levels of iPSC toward insulin-producing cells.

3. Methods

3.1. Cell Culture

The human iPSC line (R1-hiPSC1-Royan Institute, Tehran, Iran) was cultured on the layer of mitomycin-C inactivated mouse embryonic fibroblasts (MEF) and fed with an iPSC medium. The culture medium comprised Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s F12, L-glutamine, non-essential amino acids, β-mercaptoethanol, streptomycin, penicillin, ITS, b-FGF, and knockout serum replacement (KSR). The hanging drop method was conducted to generate embryoid body (EB) in the first step of differentiation. The iPSCs were differentiated toward definitive endoderm according to the method described with details in our previous study (8). The ATG5 gene expression was analyzed during differentiation, including iPSC, EB, mesendoderm (ME), and definitive endoderm (DE) stages.

3.2. Quantitative Real-time-PCR

Allprep RNA extraction kit (Qiagen, USA) and Takara (Japan) cDNA Synthesis Kit were used for total RNA extraction and complementary DNA synthesis. Quantitative RT-PCR (qRT-PCR) was performed via the StepOnePlus Real-time PCR system. We evaluated the relative mRNA expression levels by the 2-ΔΔCt method (ΔCt illustrates the difference between the ATG5 target gene and GAPDH control gene) and compared the fold changes with the non-treated hiPSC line.

The reaction mixture was made of CYBR green I master mix 2X (5 μL -Takara, Japan), ROX dye (0.2 μL), primers (10 pM each one), and 1 µL cDNA. Thermal conditioning was set as follows: one step at 95˚C (initial denaturation) for 30 s, then 40 cycles, including 95˚C for 5 s, 58˚C for 15 s, and 72˚C for 20 s. The sequence of forward and reverse primers of the ATG5 gene were 5’-GGCCATCAATCGGAAACTC-3’, 5’-AGGTCTTTCAGTCGTTGTCT-3’, and for GAPDH were 5’-GGACTCATGACCACAGTCCA-3’ and 5’-CCAGTAGAGGCAGGGATGAT-3’.

3.3. Statistical Analysis

The fold change calculation, descriptive statistics, and Graph design were performed by GenEX v.6.1, EXCEL v.2017, and GraphPad Prism v7.01 software, respectively. The different stages of differentiation were compared using One-way ANOVA with Tukey-Kramer’s post-hoc test. P-value less than 0.05 is considered significant.

4. Results

Our findings showed that the R1-hiPSC was well-cultured on the MEF layer and had a proper phenotype. The ATG5 gene expression level in several stages of cell differentiation compared with undifferentiated hiPSC. As described in previous reports, we examined the expression of pluripotency and endoderm markers to confirm cell differentiation. Our findings demonstrated that the cells were successfully induced to differentiate into endoderm.

The mRNA expression of the ATG5 gene was examined in iPSC, EB, mesendoderm (ME), and definitive endoderm (DE) stages of differentiation (Figure 1). Our results showed the low levels of ATG5 mRNA expression in iPS cells. The maximum expression of the ATG5 was observed in the MEI stage (compared with iPSC and other stages of differentiation), and then the downregulated mRNA expression level was detected. However, the high level of the ATG5 expression was found in all stages of differentiation rather than iPSC. Therefore, the comparison of the ATG5 mRNA expression during differentiation indicated high levels of autophagy in the MEI stage.

Figure 1. The mRNA expression levels of ATG5 gene in human iPSC during endoderm induction. EB: embryoid body, ME: mesendoderm, DE: definitive endoderm.

5. Discussion

Autophagy is a significant, self-degradative procedure for the regulation of energy sources during development and stress status (9). Autophagy also eliminates misfolded or aggregated components and pathogens and clears damaged organelles (10). This procedure acts at a basal level in most tissues to maintain homeostasis. Moreover, autophagy is known as a quality control mechanism for proteins and organelles (11). It modulates several necessary cellular processes, such as self-renewal, differentiation, senescence, and apoptosis (12, 13). The role of autophagy in the maintenance and differentiation processes of stem cells as well as the generation of induced pluripotent have been previously shown (14).

Recent studies have demonstrated the conclusive role of autophagy in the function and survival of pancreatic beta cells (15). In vivo experiments showed that lack of autophagy in mice caused beta-cell mass reduction and decreased insulin secretion, demonstrating the role of autophagy in normal cell homeostasis (16, 17). Also, in vitro and in vivo studies showed that the over-induction of autophagy could reduce the function of cells (18). Moreover, there are some published reports, implying the vital role of autophagy during in vitro differentiation of stem cells (19-21). The ATG5 protein is essential in the development of early lymphocyte cells, the late activation of lymphocytes, and further plasma cell differentiation. According to previous reports regarding the role of ATG5 in cell differentiation, the autophagy genes status is a crucial subject in a pluripotent stem cell during several stages of differentiation (22, 23). In the present study, we differentiated hiPSC and analyzed the expression of ATG5 autophagy marker gene during endoderm induction (iPSC, EB, MEI, DEI 1, DEI 2, and DE). Our findings showed that autophagy was activated at the definitive endoderm generation step and reached a basic level during the last steps of differentiation reported by Pantovic et al. (24).

ATG5 is one of the recognized standards to study autophagic activity (25) and a significant mediator of autophagosome formation (26). ATG5 and ATG7 are needed to elongate and maturate the autophagosome. Imperfect depletion of ATG proteins impaired autophagy, evident by downregulation of LC3-II expression (27). The physiological effect of autophagy in pancreatic beta cells was examined by Ebato et al. with the generation of the mice with Atg7 deficiency. Their results showed that mice with β-cell specific autophagy deficiency (Atg7f/f:RIP-Cre, Atg7-deficient mice) showed impaired glucose tolerance with abnormal β-cell morphology (28).

Masakazu Sugiyama et al. observed that ATG5 silencing in Liver stem/progenitor cells reduced active LC3 and enhanced p62, showing autophagy inhibition and increased hepatic differentiation in the stem/progenitor cells. In contrast, SQSTM1/p62 silencing impaired hepatic differentiation (29).

Overall, our results demonstrated a time-dependent autophagy-specific gene expression during endoderm induction. We observed that the expression of the ATG5 (autophagy gene marker) gene was in the highest levels during the MEI stage. Determining the expression pattern of autophagy genes could be used to alter autophagy procedures and attain more efficient differentiation induction tactics.

5.1. Conclusion

The current study described mRNA expression of ATG5 autophagy gene during different days of differentiation (iPSC, EB, MEI, DE1, DE2, and DE). The results showed the decreased mRNA expression of ATG5 in the early stages of differentiation (EB) and then increased at the MEI stage. According to the results, autophagy was involved during the differentiation of iPSC and early stages of differentiation rather than the later stages. Subsequent studies are needed to find the precise role of autophagy in the differentiation of iPSC and obtain more efficient tactics to differentiate human iPSC.

Footnotes

References

  • 1.

    Chen X, Li C, Chen Y, Xi H, Zhao S, Ma L, et al. Differentiation of human induced pluripotent stem cells into Leydig-like cells with molecular compounds. Cell Death Dis. 2019;10(3):220. doi: 10.1038/s41419-019-1461-0. [PubMed: 30833541]. [PubMed Central: PMC6399252].

  • 2.

    Abu-Dawud R, Graffmann N, Ferber S, Wruck W, Adjaye J. Pluripotent stem cells: induction and self-renewal. Philos Trans R Soc Lond B Biol Sci. 2018;373(1750). doi: 10.1098/rstb.2017.0213. [PubMed: 29786549]. [PubMed Central: PMC5974437].

  • 3.

    Ebert AD, Liang P, Wu JC. Induced pluripotent stem cells as a disease modeling and drug screening platform. J Cardiovasc Pharmacol. 2012;60(4):408-16. doi: 10.1097/FJC.0b013e318247f642. [PubMed: 22240913]. [PubMed Central: PMC3343213].

  • 4.

    Quiskamp N, Bruin JE, Kieffer TJ. Differentiation of human pluripotent stem cells into beta-cells: Potential and challenges. Best Pract Res Clin Endocrinol Metab. 2015;29(6):833-47. doi: 10.1016/j.beem.2015.10.011. [PubMed: 26696513].

  • 5.

    Stanekzai J, Isenovic ER, Mousa SA. Treatment options for diabetes: potential role of stem cells. Diabetes Res Clin Pract. 2012;98(3):361-8. doi: 10.1016/j.diabres.2012.09.010. [PubMed: 23020931].

  • 6.

    Chen X, He Y, Lu F. Autophagy in stem cell biology: A perspective on stem cell self-renewal and differentiation. Stem Cells Int. 2018;2018:9131397. doi: 10.1155/2018/9131397. [PubMed: 29765428]. [PubMed Central: PMC5896318].

  • 7.

    Zheng W, Xie W, Yin D, Luo R, Liu M, Guo F. ATG5 and ATG7 induced autophagy interplays with UPR via PERK signaling. Cell Commun Signal. 2019;17(1):42. doi: 10.1186/s12964-019-0353-3. [PubMed: 31060556]. [PubMed Central: PMC6503447].

  • 8.

    Ghorbani-Dalini S, Azarpira N, Sangtarash MH, Soleimanpour-Lichaei HR, Yaghobi R, Lorzadeh S, et al. Optimization of activin-A: a breakthrough in differentiation of human induced pluripotent stem cell into definitive endoderm. 3 Biotech. 2020;10(5):215. doi: 10.1007/s13205-020-02215-3. [PubMed: 32355589]. [PubMed Central: PMC7186283].

  • 9.

    Chun Y, Kim J. Autophagy: An essential degradation program for cellular homeostasis and life. Cells. 2018;7(12). doi: 10.3390/cells7120278. [PubMed: 30572663]. [PubMed Central: PMC6315530].

  • 10.

    Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3-12. doi: 10.1002/path.2697. [PubMed: 20225336]. [PubMed Central: PMC2990190].

  • 11.

    Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728-41. doi: 10.1016/j.cell.2011.10.026. [PubMed: 22078875].

  • 12.

    Wen X, Klionsky DJ. Autophagy is a key factor in maintaining the regenerative capacity of muscle stem cells by promoting quiescence and preventing senescence. Autophagy. 2016;12(4):617-8. doi: 10.1080/15548627.2016.1158373. [PubMed: 27050452]. [PubMed Central: PMC4835951].

  • 13.

    Marino G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15(2):81-94. doi: 10.1038/nrm3735. [PubMed: 24401948]. [PubMed Central: PMC3970201].

  • 14.

    Vessoni AT, Muotri AR, Okamoto OK. Autophagy in stem cell maintenance and differentiation. Stem Cells Dev. 2012;21(4):513-20. doi: 10.1089/scd.2011.0526. [PubMed: 22066548].

  • 15.

    Kong FJ, Wu JH, Sun SY, Zhou JQ. The endoplasmic reticulum stress/autophagy pathway is involved in cholesterol-induced pancreatic beta-cell injury. Sci Rep. 2017;7:44746. doi: 10.1038/srep44746. [PubMed: 28294183]. [PubMed Central: PMC5353658].

  • 16.

    Riahi Y, Wikstrom JD, Bachar-Wikstrom E, Polin N, Zucker H, Lee MS, et al. Autophagy is a major regulator of beta cell insulin homeostasis. Diabetologia. 2016;59(7):1480-91. doi: 10.1007/s00125-016-3868-9. [PubMed: 26831301]. [PubMed Central: PMC5912938].

  • 17.

    Quan W, Hur KY, Lim Y, Oh SH, Lee JC, Kim KH, et al. Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice. Diabetologia. 2012;55(2):392-403. doi: 10.1007/s00125-011-2350-y. [PubMed: 22075916].

  • 18.

    Tanemura M, Ohmura Y, Deguchi T, Machida T, Tsukamoto R, Wada H, et al. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am J Transplant. 2012;12(1):102-14. doi: 10.1111/j.1600-6143.2011.03771.x. [PubMed: 21966953].

  • 19.

    Ren L, Yang H, Cui Y, Xu S, Sun F, Tian N, et al. Autophagy is essential for the differentiation of porcine PSCs into insulin-producing cells. Biochem Biophys Res Commun. 2017;488(3):471-6. doi: 10.1016/j.bbrc.2017.05.058. [PubMed: 28501624].

  • 20.

    Lu Y, Yuan X, Ou Y, Cai Y, Wang S, Sun Q, et al. Autophagy and apoptosis during adult adipose-derived stromal cells differentiation into neuron-like cells in vitro. Neural Regen Res. 2012;7(16):1205.

  • 21.

    Li B, Duan P, Li C, Jing Y, Han X, Yan W, et al. Role of autophagy on bone marrow mesenchymal stemcell proliferation and differentiation into neurons. Mol Med Rep. 2016;13(2):1413-9. doi: 10.3892/mmr.2015.4673. [PubMed: 26676567].

  • 22.

    Riffelmacher T, Simon AK. Mechanistic roles of autophagy in hematopoietic differentiation. FEBS J. 2017;284(7):1008-20. doi: 10.1111/febs.13962. [PubMed: 27860274].

  • 23.

    Ye X, Zhou XJ, Zhang H. Exploring the role of autophagy-related gene 5 (ATG5) yields important insights into autophagy in autoimmune/autoinflammatory diseases. Front Immunol. 2018;9:2334. doi: 10.3389/fimmu.2018.02334. [PubMed: 30386331]. [PubMed Central: PMC6199349].

  • 24.

    Pantovic A, Krstic A, Janjetovic K, Kocic J, Harhaji-Trajkovic L, Bugarski D, et al. Coordinated time-dependent modulation of AMPK/Akt/mTOR signaling and autophagy controls osteogenic differentiation of human mesenchymal stem cells. Bone. 2013;52(1):524-31. doi: 10.1016/j.bone.2012.10.024. [PubMed: 23111315].

  • 25.

    Jimenez-Moreno N, Stathakos P, Caldwell MA, Lane JD. Induced pluripotent stem cell neuronal models for the study of autophagy pathways in human neurodegenerative disease. Cells. 2017;6(3). doi: 10.3390/cells6030024. [PubMed: 28800101]. [PubMed Central: PMC5617970].

  • 26.

    Pattingre S, Levine B. Bcl-2 inhibition of autophagy: a new route to cancer? Cancer Res. 2006;66(6):2885-8. doi: 10.1158/0008-5472.CAN-05-4412. [PubMed: 16540632].

  • 27.

    Klionsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol. 2007;8(11):931-7. doi: 10.1038/nrm2245. [PubMed: 17712358].

  • 28.

    Ebato C, Uchida T, Arakawa M, Komatsu M, Ueno T, Komiya K, et al. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab. 2008;8(4):325-32. doi: 10.1016/j.cmet.2008.08.009. [PubMed: 18840363].

  • 29.

    Sugiyama M, Yoshizumi T, Yoshida Y, Bekki Y, Matsumoto Y, Yoshiya S, et al. p62 promotes amino acid sensitivity of mTOR pathway and hepatic differentiation in adult liver stem/progenitor cells. J Cell Physiol. 2017;232(8):2112-24. doi: 10.1002/jcp.25653. [PubMed: 27748507].

  • Copyright © 2020, Gene, Cell and Tissue. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
    COMMENTS

    LEAVE A COMMENT HERE: